APA

Martin M., Serradji N., Dereuddre-Bosquet N., Le Pavec G., Fichet G., Lamouri A., Heymans F., Godfroid J. J., Clayette P. & Dormont D. (20010104). PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages. : Antimicrobial agents and chemotherapy.

Chicago

Martin M, Serradji N, Dereuddre-Bosquet N, Le Pavec G, Fichet G, Lamouri A, Heymans F, Godfroid J J, Clayette P and Dormont D. 20010104. PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages. : Antimicrobial agents and chemotherapy.

Harvard

Martin M., Serradji N., Dereuddre-Bosquet N., Le Pavec G., Fichet G., Lamouri A., Heymans F., Godfroid J. J., Clayette P. and Dormont D. (20010104). PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages. : Antimicrobial agents and chemotherapy.

MLA

Martin M, Serradji N, Dereuddre-Bosquet N, Le Pavec G, Fichet G, Lamouri A, Heymans F, Godfroid J J, Clayette P and Dormont D. PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages. : Antimicrobial agents and chemotherapy. 20010104.